EyePoint Pharmaceuticals OverviewEyePoint Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for EYPT.
Quarterly Other Income/Expense
$2.34M
↓ 35.64% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$10.36M
↓ 29.42% YoY
Trailing 12 months ending Mar 31, 2026